Howard Alan Fine, M.D.
Provider of world-class care at NewYork-Presbyterian
Locations and Appointments
Please contact the doctor's office to verify that your insurance is accepted.
- Blue Access
- Blue Connection
- Mediblue (Senior)
- Medicare Advantage
- Community Plan
About Howard Alan Fine, M.D.
Howard A. Fine, M.D., is the founding Director of the Brain Tumor Center at NewYork-Presbyterian Weill Cornell Medical Center and Associate Director for Translational Research at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. He is an internationally recognized leader in the field of neuro-oncology, with more than 28 years of experience in both laboratory and clinical research as well as in the care of patients with brain tumors. Dr. Fine has built large multidisciplinary brain tumor programs at top academic institutions such as the Dana Farber Cancer Institute/Harvard Medical School and the National Institutes of Health, has cared for over 20,000 patients with brain and spinal cord tumors in his career, has conducted over 100 clinical trials, published over 250 papers and book chapters on brain tumors and has run a continuously operating translational genetic/molecular laboratory devoted to a better understanding of and better therapies for brain tumors for over two decades. In his current capacity as Founder and Director of the Weill Cornell Brain Tumor Center, Dr. Fine spearheads a multidisciplinary approach consisting of neurosurgeons, radiation oncologists, pathologists, medical oncologists, neurologists and nutritionists at Weill Cornell Medicine for the purpose of developing a specific comprehensive treatment plan for each individual patient.
Dr. Howard A. Fine was recently recruited to Weill Cornell to be the Founding Director of the Brain Tumor Center in the Sandra and Edward Meyer Cancer Center and Associate Director for the Translational Research of the Weill Cornell Brain Tumor Center. He is also appointed as the Chief of the Division of Neuro-Oncology in the Department of Neurology.
Dr. Fine received his medical degree at the Mount Sinai School of Medicine in New York City, completed an internship and residency in Internal Medicine at the University of Pennsylvania in Philadelphia, and a fellowship in Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School in Boston. Dr. Fine founded and Directed the Dana-Farber Cancer Institute Center for Neuro-Oncology at Harvard Medical School, and the Neuro-Oncology Branch, at the National Institutes of Health. Dr. Fine most recently served as Chief of the Division of Hematology and Oncology and as Deputy Director of the New York University Cancer Center
Dr. Fine has a 26 year history of clinical and research work exclusively devoted to patients with brain tumors. He has run a basic and translational science laboratory continuously for those 26 years and has been involved in well over 100 brain tumor clinical trials. Dr. Fine has authored over 200 scholarly articles, reviews and book chapters in subjects all devoted to neuro-oncology/ brain tumors.
Dr. Fine welcomes patients with brain tumors who wished to seek his consultation, care, and/or clinical trials.
M.D.Mount Sinai School of Medicine1984
B.A.University of Pennsylvania1980
Attending NeurologistNewYork-Presbyterian Hospital
Professor of NeurologyWeill Cornell Medical College, Cornell University
Louis and Gertrude Feil Professor of MedicineWeill Cornell Medical College, Cornell University
Professor of Neurology in MedicineWeill Cornell Medical College, Cornell University
Professor of Neurology in Pathology and Laboratory MedicineWeill Cornell Medical College, Cornell University
News & Media
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
No External Relationships Reported